HomeMarketsSharesNovartis - CHF

Trade Novartis - CHF - NOVN CFD

Market is not available at the momentMarket information is presented
as of 2026-04-24 15:08:19
Trading Conditions
Type
This financial instrument is available for trading through CFDs and Knock-outs.

Knock-out options available only for selected countries.
Learn more about:CFDsKnock-outs
Spread0.35
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
CHF 1,000.00
Overnight funding adjustment
Charges from full value of position
-0.010843 %
(-CHF 0.54)

Trade size with leverage ~ CHF 5,000.00

Money from leverage ~CHF 4,000.00


-0.01084%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
CHF 1,000.00
Overnight funding adjustment
Charges from full value of position
-0.011379 %
(-CHF 0.57)

Trade size with leverage ~ CHF 5,000.00

Money from leverage ~CHF 4,000.00


-0.01138%
Overnight funding adjustment time21:00 (UTC)
CurrencyCHF
Min traded quantity0.1
Margin20.00%
Stock exchangeSwitzerland
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close115.85
Open115.35
1-Year Change27.04%
Day's Range111.8 - 115.35

Trade Novartis - CHF - NOVN CFD

Novartis AG (NVS) is a global pharmaceutical company.  Founded in 1996 through a merger of Ciba-Geigy and Sandoz, Novartis is headquartered in Basel, Switzerland. The firm has two divisions: Innovative Medicines and Sandoz.

Innovative Medicines offer prescription medicines and create treatments in areas of respiratory, ophthalmology, neuroscience, immunology, hepatology, dermatology, cardiovascular, renal and metabolism. 

Sandoz develops, manufactures and markets generic pharmaceuticals and biosimilars. Sandoz products include: Adakveo (crizanlizumab), Afinitor Disperz/Votubia (everolimus) and Arzerra (ofatumumab) for Oncology; and Aimovig (erenumab) for neuroscience. 

In 2020, in response to the pandemic, the company collaborated with Molecular Partners to develop ensovibep, a DARPin therapeutic candidate designed for potential use against Covid-19. 

The company’s shares have been listed on the New York Stock Exchange (NYSE) since 2000. Novartis AG stock is traded under the ticker symbol NVS. You can track live NVS share value and price history at Capital.com.

Latest shares articles

TIM logo displayed on a smartphone screen
TIM stock forecast: Form 20-F, shareholder distribution
TIM S.A. is a Brazilian telecoms operator whose recent coverage has focused on its 2025 Form 20-F filing and a board-approved 390m BRL interest-on-equity distribution. Past performance is not a reliable indicator of future results. Explore third-party TIMB price targets and technical analysis.
08:07, 20 April 2026
Smartphone displaying TIM logo placed on a laptop keyboard
Telecom Italia stock forecast
Explore third-party TIT price targets and technical analysis.
12:24, 15 April 2026
Monte dei Paschi di Siena bank logo displayed on a red sign on a building facade
BMPS stock forecast: Mediobanca merger, CEO shake-up
Banca Monte dei Paschi di Siena is an Italian bank listed on Borsa Italiana, with recent attention centred on its proposed Mediobanca merger and the March 2026 change in executive leadership. Past performance is not a reliable indicator of future results. Explore third-party BMPS price targets.
12:09, 15 April 2026
Ferrari logo displayed in yellow on a red storefront sign
Ferrari stock forecast: US tariffs, Middle East shipments
Ferrari is a Maranello-based luxury car maker whose 2026 outlook reflects US auto tariffs, suspended Middle East shipments, and a €3.5bn share buyback programme. Past performance is not a reliable indicator of future results. Explore third-party RACE price targets and technical analysis.
11:27, 15 April 2026

Read our reviews to find out more about us

Read the feedback from our clients1, whatever their experience level.
2025-07-01
P**** R******

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-22
J*** A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-22
D******

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-16
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-20
G****

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading